Hematologic Oncology Update
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:47:30
- More information
Informações:
Synopsis
Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.
